Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
BMJ Case Reports
|
April 13, 2021
Favourable outcome after a delayed complication secondary to COVID-19
Olivia Bosher, Muneer Ahmed Syed, Shiva Bikmalla
Thorax
|
April 10, 2025
64-year-old man with a raised hemidiaphragm
Lucy O'Malley, Abdisamad Ali, Ajit Thomas, et al.
Gastrointestinal Endoscopy
|
March 31, 2009
Gallstones mimicking malignancy
Shiva Bikmalla, Shyam Menon, Marta Campbell, et al.
Clinical Medicine (London, England)
|
January 25, 2012
Implications of the current UK welfare reforms for adults with cystic fibrosis
Edward F Nash, Dominic Kavanagh, Steven Williams, et al.
Clinical Medicine (London, England)
|
March 16, 2019
How should complete lung collapse secondary to primary spontaneous pneumothorax be managed?
Muhammad Badar Ganaie, Usman Maqsood, Simon Lea, et al.
ERJ Open Research
|
January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
BMJ Case Reports
|
April 13, 2021
Favourable outcome after a delayed complication secondary to COVID-19
Olivia Bosher, Muneer Ahmed Syed, Shiva Bikmalla
Thorax
|
April 10, 2025
64-year-old man with a raised hemidiaphragm
Lucy O'Malley, Abdisamad Ali, Ajit Thomas, et al.
Gastrointestinal Endoscopy
|
March 31, 2009
Gallstones mimicking malignancy
Shiva Bikmalla, Shyam Menon, Marta Campbell, et al.
Clinical Medicine (London, England)
|
January 25, 2012
Implications of the current UK welfare reforms for adults with cystic fibrosis
Edward F Nash, Dominic Kavanagh, Steven Williams, et al.
Clinical Medicine (London, England)
|
March 16, 2019
How should complete lung collapse secondary to primary spontaneous pneumothorax be managed?
Muhammad Badar Ganaie, Usman Maqsood, Simon Lea, et al.
ERJ Open Research
|
January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Giles Dixon, Samuel Hague, Sarah Mulholland, et al.
Page
of 1